The vaccine candidate uses synthetic messenger RNA to activate the immune system against the virus.
United States:
Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, said on Wednesday that it would be difficult to distribute vaccines using messenger RNA technology in developing countries, due to their need for cold storage.
The comments come days after Pfizer Inc said its investigational COVID-19 vaccine was more than 90% effective based on initial trial results and planned to file for emergency clearance with states -United this month.
The vaccine candidate uses synthetic messenger RNA to activate the immune system against the virus and should be kept at minus 70 degrees Celsius (-94 F) or below.
“There are kind of cold chain challenges there. In a country like the UK and US we can tackle it and it would still be difficult. But, probably much more difficult in the countries of the United States. developing world, “Fauci told the Financial Times Global Pharmaceuticals and Biotechnology Conference.
Moderna Inc’s experimental vaccine, which is set to report the first data from an advanced trial later this month, also uses mRNA technology and must be stored at minus 20 degrees Celsius (-4 F ).
“This is the reason why when we are developing our plan … we want to have a diversity of what we call vaccine platforms. It’s not just mRNA… there are three separate platforms that are under investigation in the United States, ”Mr. Fauci said.
(Except for the title, this story was not edited by GalacticGaming staff and is posted from a syndicated feed.)
